• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性慢性肝衰竭:重症监护病房的客观入院及支持标准

Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.

作者信息

Dong Victor, Karvellas Constantine J

机构信息

Division of Gastroenterology, University of Alberta, Edmonton, Canada.

Department of Critical Care Medicine, University of Alberta, Edmonton, Canada.

出版信息

JHEP Rep. 2019 Mar 18;1(1):44-52. doi: 10.1016/j.jhepr.2019.02.005. eCollection 2019 May.

DOI:10.1016/j.jhepr.2019.02.005
PMID:32039351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7001553/
Abstract

Cirrhosis is a leading cause of morbidity and mortality throughout the world. Significant complications include variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, and infection. When these complications are severe, admission to the intensive care unit (ICU) is often required for organ support and management. Intensive care therapy can also serve as a bridge to liver transplantation. Along with decompensation of cirrhosis, the concept of acute-on-chronic liver failure (ACLF) has emerged. This involves an acute precipitating event, such as the development of infection in a patient with cirrhosis, which leads to acute deterioration of hepatic function and extrahepatic organ failure. Extrahepatic complications often include renal, cardiovascular, and respiratory failures. Patients with significant extrahepatic and hepatic failures need ICU admission for organ support. Again, in patients who are deemed suitable liver transplant candidates, intensive care management may allow bridging to liver transplantation. However, patients with a Chronic Liver Failure Consortium ACLF score greater than 70 at 48 to 72 hours post-ICU admission do not seem to benefit from ongoing intensive support and a palliative approach may be more appropriate.

摘要

肝硬化是全球发病和死亡的主要原因。严重并发症包括静脉曲张出血、肝性脑病、肝肾综合征和感染。当这些并发症严重时,往往需要入住重症监护病房(ICU)进行器官支持和管理。重症监护治疗也可作为肝移植的桥梁。随着肝硬化失代偿,急性慢性肝衰竭(ACLF)的概念应运而生。这涉及急性促发事件,如肝硬化患者发生感染,导致肝功能急性恶化和肝外器官衰竭。肝外并发症通常包括肾、心血管和呼吸衰竭。有严重肝外和肝功能衰竭的患者需要入住ICU进行器官支持。同样,对于被认为适合肝移植的患者,重症监护管理可能有助于过渡到肝移植。然而,在ICU入院后48至72小时慢性肝衰竭协会ACLF评分大于70的患者似乎无法从持续的重症支持中获益,采取姑息治疗方法可能更为合适。

相似文献

1
Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit.急性慢性肝衰竭:重症监护病房的客观入院及支持标准
JHEP Rep. 2019 Mar 18;1(1):44-52. doi: 10.1016/j.jhepr.2019.02.005. eCollection 2019 May.
2
Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure.CLIF-C急性慢性肝衰竭评分与MELD评分在预测急性慢性肝衰竭患者ICU死亡率中的比较
Cureus. 2020 Feb 24;12(2):e7087. doi: 10.7759/cureus.7087.
3
The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.重症监护病房的急性慢性肝衰竭患者的治疗过程和结果与其他人群相当。
J Hepatol. 2018 Oct;69(4):803-809. doi: 10.1016/j.jhep.2018.04.025. Epub 2018 May 4.
4
Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.验证 CLIF-C ACLF 评分是否能够确定慢性加急性肝衰竭患者接受强化治疗支持的无效阈值。
Crit Care. 2018 Oct 10;22(1):254. doi: 10.1186/s13054-018-2156-0.
5
Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.肝内和肝外损伤对慢加急性肝衰竭预后的影响。
J Clin Exp Hepatol. 2017 Mar;7(1):9-15. doi: 10.1016/j.jceh.2016.10.006. Epub 2016 Oct 29.
6
Lactate and number of organ failures predict intensive care unit mortality in patients with acute-on-chronic liver failure.乳酸和器官衰竭数量可预测慢加急性肝衰竭患者的重症监护病房死亡率。
Liver Int. 2019 Jul;39(7):1271-1280. doi: 10.1111/liv.14083. Epub 2019 Mar 19.
7
Intensive care management of acute-on-chronic liver failure.慢性加急性肝衰竭的重症监护管理。
Intensive Care Med. 2023 Aug;49(8):903-921. doi: 10.1007/s00134-023-07149-x. Epub 2023 Aug 8.
8
Management of the acute on chronic liver failure in the intensive care unit.重症监护病房中慢性肝功能衰竭急性发作的管理。
Liver Int. 2025 Mar;45(3):e15659. doi: 10.1111/liv.15659. Epub 2023 Jun 27.
9
Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.肝损伤引起的慢加急性肝衰竭与肝外损伤引起的慢加急性肝衰竭不同。
Hepatology. 2015 Jul;62(1):232-42. doi: 10.1002/hep.27795. Epub 2015 Apr 25.
10
The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure.重症监护病房中的肝硬化患者与慢加急性肝衰竭的管理
J Intensive Care Soc. 2022 Feb;23(1):78-86. doi: 10.1177/1751143720978849. Epub 2020 Dec 28.

引用本文的文献

1
Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients.双能CT肝脏脂肪分数作为危重症患者的预后影像生物标志物
Eur Radiol. 2025 Aug 6. doi: 10.1007/s00330-025-11851-3.
2
Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations.白蛋白:市场趋势、纯化方法及生物医学创新综述
Curr Issues Mol Biol. 2025 Apr 26;47(5):303. doi: 10.3390/cimb47050303.
3
Nonlinear association between AST/ALT ratio and 28-day all-cause mortality following ICU admission in critically ill cirrhotic patients: a retrospective cohort study.危重症肝硬化患者入住重症监护病房后谷草转氨酶/谷丙转氨酶比值与28天全因死亡率之间的非线性关联:一项回顾性队列研究
BMC Gastroenterol. 2025 May 13;25(1):367. doi: 10.1186/s12876-025-03966-0.
4
Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival.血清脂联素在重症肝病患者中升高,并与总体生存率降低相关。
Biomedicines. 2024 Sep 25;12(10):2173. doi: 10.3390/biomedicines12102173.
5
Barriers and Strategies to Effective Serious Illness Communication for Patients with End-Stage Liver Disease in the Intensive Care Setting.重症监护环境下终末期肝病患者有效重症疾病沟通的障碍与策略
J Intensive Care Med. 2024 Sep 9:8850666241280892. doi: 10.1177/08850666241280892.
6
Intensive care unit admission criteria: a scoping review.重症监护病房收治标准:一项范围综述
J Intensive Care Soc. 2024 Apr 15;25(3):296-307. doi: 10.1177/17511437241246901. eCollection 2024 Aug.
7
[When should a liver disease patient be admitted to the intensive care unit?].[肝病患者何时应入住重症监护病房?]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):470-477. doi: 10.1007/s00063-024-01160-w. Epub 2024 Jul 17.
8
Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit.开发和验证 ICU 中慢加急性肝衰竭患者的新预后模型。
World J Gastroenterol. 2024 May 28;30(20):2657-2676. doi: 10.3748/wjg.v30.i20.2657.
9
Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study.失代偿期肝硬化的重症监护结局:美国全国住院患者样本横断面研究。
Crit Care. 2024 May 7;28(1):150. doi: 10.1186/s13054-024-04938-8.
10
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4 T-cell exhaustion.BTLA 通过耗尽 CD4 T 细胞导致慢加急性肝衰竭感染和死亡。
Nat Commun. 2024 Feb 28;15(1):1835. doi: 10.1038/s41467-024-46047-8.

本文引用的文献

1
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.全球肝硬化患者细菌感染的流行病学和影响。
Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.
2
Intensive Care Therapy for Patients with Advanced Liver Diseases.晚期肝病患者的重症监护治疗
Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.
3
Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure.验证 CLIF-C ACLF 评分是否能够确定慢性加急性肝衰竭患者接受强化治疗支持的无效阈值。
Crit Care. 2018 Oct 10;22(1):254. doi: 10.1186/s13054-018-2156-0.
4
Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis.欧洲和北美的 ICU 中多器官衰竭的危重症肝硬化患者的动态预后:一项多中心分析。
Crit Care Med. 2018 Nov;46(11):1783-1791. doi: 10.1097/CCM.0000000000003369.
5
Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.特利加压素在慢性肝衰竭急性加重期急性肾损伤管理中优于去甲肾上腺素。
Hepatology. 2020 Feb;71(2):600-610. doi: 10.1002/hep.30208. Epub 2019 Feb 20.
6
Liver transplantation in patients with multiple organ failures: Feasibility and outcomes.肝移植治疗多器官功能衰竭患者:可行性和结局。
J Hepatol. 2018 Nov;69(5):1047-1056. doi: 10.1016/j.jhep.2018.07.007. Epub 2018 Jul 31.
7
Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?急、慢性肝衰竭:准备好迎来黄金时代了吗?
Hepatology. 2018 Oct;68(4):1621-1632. doi: 10.1002/hep.30056. Epub 2018 Sep 22.
8
The Surviving Sepsis Campaign Bundle: 2018 update.拯救脓毒症运动集束化治疗方案:2018年更新版
Intensive Care Med. 2018 Jun;44(6):925-928. doi: 10.1007/s00134-018-5085-0. Epub 2018 Apr 19.
9
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
10
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.急慢性肝衰竭程度与肝肾综合征患者特利加压素和白蛋白反应的关系。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.